期刊文献+

营养与肿瘤表观遗传学关系的研究进展——组蛋白修饰机制 被引量:6

Research Progress on the Relationship between Nutrition and Cancer Epigenetics——Histone Modification Mechanisms
下载PDF
导出
摘要 表观遗传学是研究没有DNA序列变化,但可遗传的基因表达(活性)的改变。目前认为表观遗传的信息包括核小体构型的变化(ATP依赖的染色体重构);基因组印记;X染色体失活;DNA甲基化;染色体蛋白的改变,包括组蛋白的修饰如乙酰化、甲基化、磷酸化、多聚ADP-核糖基化、赖氨酸残基(Lys)的生物素(酰)化等,组蛋白变体的替换,非组蛋白的改变;非编码RNA调控转录。长期以来人们一直认为基因突变参与肿瘤的形成,近年来越来越多的证据表明,肿瘤的形成受遗传学修饰和表观遗传修饰的影响,表观遗传修饰在肿瘤进展中同样具有非常重要的作用。饮食是影响健康的重要因素,与肿瘤关系密切。本文对有关表观遗传学的组蛋白修饰机制的研究作一综述,并分别对目前其在肿瘤发生、发展的分子机制研究中所起作用及其在肿瘤预防和治疗的应用方面进行初步总结;概述了食物营养与肿瘤表观遗传学组蛋白修饰机制关系的近期研究情况。 Epigenetics is the study of processes that establish metastable ( that is, somatically heritable) state of gene expression without altering the sequence. Epigenetic information includes nucleosome remodeling; genomic imprinting; X chromosome inactivation; DNA methylation; chromosome protein changes, including histone modification [acetylation, methylation, phosphorylation, poly (ADP-ribosylation) , lysine (K) residue biotinylation, and so on] , histone variants exchange, non-histone changes; and uncoding RNA-regulating transcription. Carcinogenesis springs from the combined forces of both genetic and epigenetic events. Although the importance of genetic mutations in cancer has long been recognized , the role of epigenetic modification has been suggested more recently. Nutrients play essential roles in human health, and may modify cancer risk. This article sumed up recent researches on histone modification mechanism, approached the molecular mechanism during cancer initiation and development and the application in cancer prevention and treatment in histone modification level respectively, and summarized the relationship between diet nutrition and cancer epigenetic mechanism in histone modification level.
作者 腾丽娟 李克
出处 《癌症》 SCIE CAS CSCD 北大核心 2007年第9期1034-1038,共5页 Chinese Journal of Cancer
基金 日本文部省科学技术优先项目~~
关键词 表观遗传学 组蛋白修饰 肿瘤 食物营养 Epigenetics Histone modification Neoplasm Diet nutrition
  • 相关文献

参考文献45

  • 1Wolffe A P,Matzke M A. Epigenetics: regulation through repression [J]. Science, 1999,286(5439) :481-486.
  • 2吴南,桂建芳.组蛋白变体及组蛋白替换[J].遗传,2006,28(4):493-500. 被引量:6
  • 3Linggi B E, Brandt S J, Sun Z W, et al. Translating the histone code into leukemia IJ]. J Cell Biochem, 2005, 96(5) :938-950.
  • 4滕玥,戴冬秋.胃癌表遗传学的研究进展[J].世界华人消化杂志,2005,13(19):2289-2293. 被引量:15
  • 5Klose R J, Kauin E M, Zhang Y. JmjC-domain-containing proteins and histone demethylation [ J ]. Nat Rev Genet, 2006,7(9) :715-727.
  • 6张永彪,褚嘉祐.表观遗传学与人类疾病的研究进展[J].遗传,2005,27(3):466-472. 被引量:49
  • 7Yang X J, Ogryzko V V, Nishikawa J, et al. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A [J]. Nature, 1996,382(6589) : 319-324.
  • 8Kondo T, Oue N, Mitani Y, et al. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma [J]. Oncogene, 2005,24( 1 ) : 157-164.
  • 9Mitani Y, Oue N, Hamai Y, et al. Histone H3 acetylation is associated with reduced p21 (WAF1/CIP1) expression by gastric carcinoma [J]. J Pathol, 2005,205( 1 ) :65-73.
  • 10Hamai Y, Oue N, Mitani Y, et al. DNA hypermethylation and histone hypoacetylation of the HLTF gene associated with reduced expression in gastric carcinoma [J]. Cancer Sci, 2003,94(8):692-698.

二级参考文献141

  • 1Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene 2001; 20:3139-3155.
  • 2Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science 1999; 286:481-486.
  • 3Gitan RS, Shi H, Chen CM, Yan PS, Huang TH. Methylationspecific oligonucleotide microarray: a new potential for highthroughput methylation analysis. Genome Res 2002; 12:158-164.
  • 4Lee YY, Kang SH, Seo JY, Jung CW, Lee KU, Choe KJ, Kim BK,Kim NK, Koeffler HP, Bang YJ. Alterlations of p16^IK4n and p15^INK4s genes in gastric carcinoma. Cancer 1997; 80:1889-1896.
  • 5Lee TL, Leung WK, Chan MW, Ng EK, Tong JH, Lo KW,Chung SC, Sung JJ, To KF. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 2002; 8:1761-1766.
  • 6Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG.CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61:2847-2851.
  • 7Shim YH, Kang GH, Ro JY. Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. LabInvest 2000; 80:689-695.
  • 8Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab Invest 2003; 83:519-526.
  • 9Bai H, Gu L, Zhou J, Deng D. p16 hypermethylation during gastric carcinogenesis of Wistar rats by N-methyl-N'-nitro-N-nitrosoguanidine. Mutat Res 2003; 535:73-78.
  • 10Fleisher AS, EsteUer M, Wang S, Tamura G, Suzuki H, Yin J,Zou TT, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG, Meltzer SJ. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999;59:1090-1095.

共引文献80

同被引文献89

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部